BCAN News
Event: Examining the Use of Checkpoint Inhibitors in Bladder Cancer
Examining the Use of Checkpoint Inhibitors in Bladder Cancer Thursday, December 5, 2019 Renaissance Capital Ballroom Washington, DC More information and registration Speakers Robert Dreicer, MD, MS, MACP, FASCO University of Virginia School of Medicine Charlottesville, Virginia Dr. Dreicer is the Associate Director for Clinical Research and the Deputy Director
The Bladder Cancer Advocacy Network Sends Well Wishes to New York State Senator James Seward
(November 7, 2019, Bethesda, Maryland) The Bladder Cancer Advocacy Network was saddened to learn of State Senator James Seward’s (NY-51) recurrence of bladder cancer, announced yesterday. Senator Seward was first diagnosed in 2016. “We send our best wishes to Senator Seward and his family for a speedy and complete recovery,”
BCAN Earns Coveted 4-Star Charity Navigator Ranking for Fifth Consecutive Year
October 17, 2019, Bethesda, Maryland – The Bladder Cancer Advocacy Network’s (BCAN’s) strong financial health and commitment to accountability and transparency have earned it a 4-star rating from Charity Navigator, America’s largest independent charity evaluator. BCAN has earned this top distinction in each of the last five years, putting it
World Bladder Cancer Patient Coalition Appoints First Executive Director
October 1, 2019, Brussels – Today, the World Bladder Cancer Patient Coalition announced the appointment of Alex Filicevas as the organization’s first Executive Director. Alex comes from the largest cancer patient umbrella organization in Europe, the European Cancer Patient Coalition, where he led advocacy and policy initiatives, capacity building and
Diane Zipursky Quale’s Interview with OncoZine Brief
Our co-founder, Diane Zipursky Quale, was a guest on Onco’Zine Brief, a leading podcast in the cancer scientific and advocacy communities, discussing bladder cancer. Among other topics, Diane talks about: What bladder cancer is and who it impacts; The role that BCAN plays in advocating for increased awareness and funding
BCAN Announces 2019 Bladder Cancer Research Innovation Awardee
BCAN’s Bladder Cancer Research Innovation Award supports exceptionally novel and creative projects with great potential to produce breakthroughs in the management of bladder cancer. The 2019 awardee is Philip Beachy, Ph.D., Professor of Urology and of Developmental Biology at the Stanford University School of Medicine. His research project addresses the
Bladder Cancer Advocacy Network Selects Mark Story as First-ever Director of Communications and Marketing
Bethesda, MD (July 2, 2019) – The Bladder Cancer Advocacy Network (BCAN), the only national advocacy organization devoted to advancing bladder cancer research and treatment and supporting those impacted by the disease, has hired strategic communications and marketing strategist Mark Story as its first-ever Director of Communications and Marketing. Story
FDA-BCAN Workshop
Co-sponsored by the: U.S. Food and Drug Administration (FDA) and the Bladder Cancer Advocacy Network (BCAN) Date: Thursday, August 8, 2019 from Noon-4PM EST Location: Capital Hilton, 1001 16th Street NW, Washington, DC 20036 Cost: Free – WebEx Only Neoadjuvant cisplatin-based combination chemotherapy followed by radical cystectomy is a standard